Pneumo 23™

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, Streptococcal

Phase 1

Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population

CompletedNCT00327665

GlaxoSmithKlineInfections, Streptococcal

Start: 2006-05-01End: 2007-01-08Updated: 2017-05-08

Evaluation of Pneumococcal Vaccine Formulations in Young Adults

CompletedNCT00707798

GlaxoSmithKlineInfections, Streptococcal

Start: 2008-06-30End: 2009-01-15Updated: 2017-05-10

Evaluation of Pneumococcal Vaccine Formulations in Elderly

CompletedNCT00756067

GlaxoSmithKlineInfections, Streptococcal

Start: 2008-09-19End: 2009-05-28Updated: 2017-05-10

Related Papers

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study.

2014-03-0652 citations

Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02 <sub>V</sub> in Elderly Adults

Clinical and Vaccine Immunology2014-03-0641 citations